Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos

Background: IgG4-related disease (IgG4 RD) is an immune-mediated fibro-inflammatory disorder, with tissue infiltration of IgG4+ plasma cells. It causes pseudotumors, tumors, and a wide spectrum of clinical manifestations. Aim: To report the clinical, laboratory, histopathological and treatment characteristics of a group of Chilean patients with IgG4 RD. Material and Methods: Review of medical records of 52 patients aged 18 to 76 years with IgG4 RD seen at six medical centers. Results: Elevated IgG4 serum levels (> 135 mg/dl) were found in 18 of 44 (41%) patients. There was histological confirmation of the disease in 46 patients. The most common sites of involvement were lungs, eyes and kidneys. Eighteen (35%) patients had only one organ involved, 34 (65%) patients had two organs and 13 (25%) patients had three or more organs. The involvement of two organs was significantly more common in men (p < 0.05). In patients with only one organ involvement, the most frequent location was orbital and meningeal. All patients with kidney or lung disease had multiorgan involvement. All patients received corticosteroid therapy, 67% synthetic immunosuppressants, and 16% rituximab. Conclusions: ER-IgG4 can affect any tissue. Multiorgan involvement was more common in this series, with preference for lungs, eyes and kidneys. An excellent response to steroids is characteristic of the disease, but with a high relapse rate that requires additional immunosuppression.

Saved in:
Bibliographic Details
Main Authors: Cuéllar,María C., Gutiérrez,Miguel, Herrera,Alejandra, Elgueta,Fabián, Wurmann,Pamela, Badilla,Natalia, Mansilla,Bellanides, Basualdo,Javier, Vega,Jorge, Erlij,Daniel, Labarca,Cristian, Vergara,Cristian, Mezzano,Verónica, Méndez,Ignacio, Stange,Lilith, Michalland,Susana, Silva,Francisco, Jara,Aquiles, Goecke,Annelise, Burgos,Paula, Iruretagoyena,Mirentxu, Fernández,Cristina, Landeros,Carolina, Neira,Óscar
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2022
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000600705
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872022000600705
record_format ojs
spelling oai:scielo:S0034-988720220006007052022-12-18Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenosCuéllar,María C.Gutiérrez,MiguelHerrera,AlejandraElgueta,FabiánWurmann,PamelaBadilla,NataliaMansilla,BellanidesBasualdo,JavierVega,JorgeErlij,DanielLabarca,CristianVergara,CristianMezzano,VerónicaMéndez,IgnacioStange,LilithMichalland,SusanaSilva,FranciscoJara,AquilesGoecke,AnneliseBurgos,PaulaIruretagoyena,MirentxuFernández,CristinaLanderos,CarolinaNeira,Óscar Immunoglobulin G4-Related Disease Background: IgG4-related disease (IgG4 RD) is an immune-mediated fibro-inflammatory disorder, with tissue infiltration of IgG4+ plasma cells. It causes pseudotumors, tumors, and a wide spectrum of clinical manifestations. Aim: To report the clinical, laboratory, histopathological and treatment characteristics of a group of Chilean patients with IgG4 RD. Material and Methods: Review of medical records of 52 patients aged 18 to 76 years with IgG4 RD seen at six medical centers. Results: Elevated IgG4 serum levels (> 135 mg/dl) were found in 18 of 44 (41%) patients. There was histological confirmation of the disease in 46 patients. The most common sites of involvement were lungs, eyes and kidneys. Eighteen (35%) patients had only one organ involved, 34 (65%) patients had two organs and 13 (25%) patients had three or more organs. The involvement of two organs was significantly more common in men (p < 0.05). In patients with only one organ involvement, the most frequent location was orbital and meningeal. All patients with kidney or lung disease had multiorgan involvement. All patients received corticosteroid therapy, 67% synthetic immunosuppressants, and 16% rituximab. Conclusions: ER-IgG4 can affect any tissue. Multiorgan involvement was more common in this series, with preference for lungs, eyes and kidneys. An excellent response to steroids is characteristic of the disease, but with a high relapse rate that requires additional immunosuppression.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.150 n.6 20222022-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000600705es10.4067/S0034-98872022000600705
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Cuéllar,María C.
Gutiérrez,Miguel
Herrera,Alejandra
Elgueta,Fabián
Wurmann,Pamela
Badilla,Natalia
Mansilla,Bellanides
Basualdo,Javier
Vega,Jorge
Erlij,Daniel
Labarca,Cristian
Vergara,Cristian
Mezzano,Verónica
Méndez,Ignacio
Stange,Lilith
Michalland,Susana
Silva,Francisco
Jara,Aquiles
Goecke,Annelise
Burgos,Paula
Iruretagoyena,Mirentxu
Fernández,Cristina
Landeros,Carolina
Neira,Óscar
spellingShingle Cuéllar,María C.
Gutiérrez,Miguel
Herrera,Alejandra
Elgueta,Fabián
Wurmann,Pamela
Badilla,Natalia
Mansilla,Bellanides
Basualdo,Javier
Vega,Jorge
Erlij,Daniel
Labarca,Cristian
Vergara,Cristian
Mezzano,Verónica
Méndez,Ignacio
Stange,Lilith
Michalland,Susana
Silva,Francisco
Jara,Aquiles
Goecke,Annelise
Burgos,Paula
Iruretagoyena,Mirentxu
Fernández,Cristina
Landeros,Carolina
Neira,Óscar
Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
author_facet Cuéllar,María C.
Gutiérrez,Miguel
Herrera,Alejandra
Elgueta,Fabián
Wurmann,Pamela
Badilla,Natalia
Mansilla,Bellanides
Basualdo,Javier
Vega,Jorge
Erlij,Daniel
Labarca,Cristian
Vergara,Cristian
Mezzano,Verónica
Méndez,Ignacio
Stange,Lilith
Michalland,Susana
Silva,Francisco
Jara,Aquiles
Goecke,Annelise
Burgos,Paula
Iruretagoyena,Mirentxu
Fernández,Cristina
Landeros,Carolina
Neira,Óscar
author_sort Cuéllar,María C.
title Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
title_short Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
title_full Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
title_fullStr Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
title_full_unstemmed Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos
title_sort enfermedad relacionada a igg4. serie clínica de pacientes chilenos
description Background: IgG4-related disease (IgG4 RD) is an immune-mediated fibro-inflammatory disorder, with tissue infiltration of IgG4+ plasma cells. It causes pseudotumors, tumors, and a wide spectrum of clinical manifestations. Aim: To report the clinical, laboratory, histopathological and treatment characteristics of a group of Chilean patients with IgG4 RD. Material and Methods: Review of medical records of 52 patients aged 18 to 76 years with IgG4 RD seen at six medical centers. Results: Elevated IgG4 serum levels (> 135 mg/dl) were found in 18 of 44 (41%) patients. There was histological confirmation of the disease in 46 patients. The most common sites of involvement were lungs, eyes and kidneys. Eighteen (35%) patients had only one organ involved, 34 (65%) patients had two organs and 13 (25%) patients had three or more organs. The involvement of two organs was significantly more common in men (p < 0.05). In patients with only one organ involvement, the most frequent location was orbital and meningeal. All patients with kidney or lung disease had multiorgan involvement. All patients received corticosteroid therapy, 67% synthetic immunosuppressants, and 16% rituximab. Conclusions: ER-IgG4 can affect any tissue. Multiorgan involvement was more common in this series, with preference for lungs, eyes and kidneys. An excellent response to steroids is characteristic of the disease, but with a high relapse rate that requires additional immunosuppression.
publisher Sociedad Médica de Santiago
publishDate 2022
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000600705
work_keys_str_mv AT cuellarmariac enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT gutierrezmiguel enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT herreraalejandra enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT elguetafabian enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT wurmannpamela enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT badillanatalia enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT mansillabellanides enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT basualdojavier enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT vegajorge enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT erlijdaniel enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT labarcacristian enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT vergaracristian enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT mezzanoveronica enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT mendezignacio enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT stangelilith enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT michallandsusana enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT silvafrancisco enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT jaraaquiles enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT goeckeannelise enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT burgospaula enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT iruretagoyenamirentxu enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT fernandezcristina enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT landeroscarolina enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
AT neiraoscar enfermedadrelacionadaaigg4serieclinicadepacienteschilenos
_version_ 1755988720750690304